Skip to main content

New top story from Time: FDA Panel Greenlights First Single-Shot COVID-19 Vaccine, from Johnson & Johnson

https://ift.tt/3pZf3dk

The U.S. Food and Drug Administration’s (FDA) vaccine advisory committee earlier today (Feb. 26) voted unanimously to recommend Johnson & Johnson’s COVID-19 vaccine for emergency use authorization. While the FDA isn’t obligated to follow the committee’s advice, it generally does.

At the end of a full day of review and discussion of the company’s shot, all 22 voting members of the committee agreed that the vaccine was safe and effective enough to be used by the public. It’s the third vaccine that the group of independent experts has recommended, following Pfizer-BioNTech and Moderna. Unlike the two previous vaccines, J&J’s is a single shot, and can be shipped and stored under refrigerated, not frozen conditions, as the other two require.

The single dosing played a part in the committee’s decision. Logistically, vaccinating people one time is much easier than asking them to return for a second dose. “This was a relatively easy call,” Dr. Eric Rubin, editor in chief of the New England Journal of Medicine and professor at Harvard T.H. Chan School of Public Health, who voted to recommend the shot said during the discussion. “[The vaccine] clearly gets way over the bar of safety and efficacy, and it’s a single-dose vaccine.”

The committee members reviewed data presented by Janssen Pharmaceuticals, the J&J arm that developed the vaccine, as well as FDA scientists’ review of that data. Janssen’s vaccine uses a different technology than Pfizer-BioNTech and Moderna, which both relied on a new platform involving mRNA. Janssen’s vaccine, on the other hand, is made with a weakened cold virus that can’t cause disease, manipulated so that it carries the genes for making one of the key proteins of SARS-CoV-2, the virus that causes COVID-19. Once that viral protein is introduced to the body, human immune cells learn to recognize it as foreign and launch attacks against it.

In Janssen’s primary vaccine study, involving nearly 44,000 people, a single dose was found to be 66% effective in protecting people from moderate to severe COVID-19 disease. It was slightly less effective in protecting against new variants of the virus—against one that was first identified in South Africa, it was around 57%. Still, that protection met the threshold of 50% efficacy set by the FDA for granting emergency use authorization.

Committee members raised questions about how much of the immune response to the COVID-19 virus might be blunted by a response mounted against the weakened cold virus used as the delivery vessel, a well known effect using this vaccine platform. Such vaccines are also potentially less effective when boosted with additional shots since the body becomes tolerant to the weakened virus vector. However, Dr. Johan Van Hoof, managing director of Janssen Vaccines and Prevention, noted that tests on the company’s HIV vaccine candidate using similar technology have shown that people boosted with additional shots years after the first continued to generate strong immune responses that didn’t seem to be significantly affected by the weakened virus vector.

Many committee members raised questions about the company’s data showing that the vaccine produced a slightly lower response in terms of antibody levels against the virus among people over age 60, especially those with underlying health conditions—a group particularly vulnerable to COVID-19. However, Janssen studies found that these people still did not develop severe COVID-19 disease or need hospitalization compared to people getting placebo. In fact, the vaccine was 85% effective in protecting people from severe disease and overall there were only 21 deaths among the 44,000 people studied; five occurring among those who were vaccinated and the remainder among the placebo group. None of the deaths were considered related to the vaccine.

The FDA scientists did note in their review that some participants in the study did experience serious side effects, including tinnitus (ringing in the ears), clotting and hives—which could be related to the vaccine and are worth further follow up. However, these were rare, and overall the vaccine was safe with most who reported side effects having only mild to moderate reactions including headache, chills and muscle aches.

The other question that continued to pop up during the day-long discussion focused on whether Janssen’s vaccine is really a one-shot vaccine or whether it, like the Pfizer-BioNTech and Moderna vaccines, actually requires a two-shot regimen. While the data the company submitted were from a trial in which participants were given only a single dose, the company is currently conducting another study of 30,000 people who will receive two doses of the shot—to see if an additional booster will raise immune responses even further.

If two doses prove to be more effective, it will raise a tricky question about what to do with people who might receive the single dose shot in coming weeks or months, should the one-dose regimen be authorized. Van Hoof argues that this is a question worth putting off for later, given the urgency of the current situation. “We feel the results of the study of our single dose showed high efficacy against severe disease, especially hospitalizations and death, and in a situation of mass vaccination programs, our regimen is extremely well positioned to be used during the outbreak,” he said.

Then of course there is the question of the recently identified genetic variants of SARS-CoV-2 that appear even more infectious than the original virus. Pfizer-BioNTech and Moderna did not have to deal with that when they submitted their requests back in December 2020, but the companies have since conducted additional tests that have shown that their vaccines remain effective in protecting against the major new mutations. Janssen’s submission to the FDA included some early data on the efficacy of its vaccine against the new variants, and Van Hoof told the committee that the company plans to continue genetic sequencing virus from people in the company’s trials if they test positive and will include that information in the final request for full approval which could come later this year. In the meanwhile, Janssen—like Pfizer-BioNtech and Moderna—is already working on a next-generation vaccine specifically targeting the new variants that could begin human testing by summer.

The FDA committee’s decision to recommend the Janssen shot now goes to the agency. If the FDA agrees to grant the emergency use authorization, the next step will be for the Centers for Disease Control and Prevention’s immunization committee to work out details of who should be vaccinated with the new shot, and the logistics for how to make that happen. That CDC committee will also likely make decisions about whether certain groups should be targeted to receive this specific vaccine, and what advice to provide vaccinators when people ask about whether they will need a second shot. That information won’t be available until Janssen completes its two-dose study in coming months.

Comments

Popular posts from this blog

New top story from Time: Facebook Wanted to Be a Force for Good in Myanmar. Now Its Rejecting a Request to Help With a Genocide Investigation

https://ift.tt/2DT0fLt Just when it seemed like Facebook’s controversies might have peaked, the company now appears to be obstructing a genocide investigation , and it’s using U.S. law to do it. The West African nation The Gambia is seeking to hold Myanmar accountable for charges of genocide against the Rohingya people , an ethnic and religious minority. In 2016 and 2017, Myanmar soldiers and their civilian proxies massacred Rohingya men, women and children, raped women and girls and razed villages, forcing more than 800,000 to flee into neighboring Bangladesh. Facebook’s role in these atrocities isn’t news. In 2018, Facebook acknowledged it was used to “foment division and incite offline violence” in Myanmar, where the social media platform is so ubiquitous it’s often synonymous with the internet. An independent report commissioned by the company documented the same, as did independent fact-finders appointed by the U.N. In response, Facebook took down the account ...

Powered Scooters Charge City’s Transportation Recovery

Powered Scooters Charge City’s Transportation Recovery By Jason Hyde The SFMTA is releasing its next round of Powered Scooter Share permits on July 1. Scooters remain a sustainable mode of travel and a complement to Muni and public transit service as the city recovers from the pandemic and San Franciscans begin to travel more. The SFMTA’s Powered Scooter Share Program is essential in ensuring that shared scooter operations support the city’s economic recovery in a safe, sustainable, and equitable way.  The SFMTA received four submittals for the permit program and will issue permits to two operators : Spin and Lime. Permits will be in effect for a one-year term, with the option to extend for another year at the discretion of the SFMTA based on compliance with various program metrics. While the new permit program does not set a limit on the number of scooters each operator may deploy, it does limit the overall citywide fleet size at 10,000. Starting at a base of 2,000 scooters...

New top story from Time: TikTok Gets Reprieve in U.S. as Judge Temporarily Blocks Trump’s App Store Ban

https://ift.tt/3ifHL60 President Donald Trump’s ban on TikTok was temporarily blocked by a federal judge, dealing a blow to the government in its showdown with the popular Chinese-owned app it says threatens national security. U.S. District Judge Carl Nichols granted a preliminary injunction against the ban on the widely used video-sharing network after an unusual Sunday morning hearing. The judge refused to grant an injunction against a November deadline for a sale. TikTok’s owner, ByteDance Ltd., had requested the hold after the president ordered TikTok out of American app stores unless the company sold a stake in its U.S. operations to a domestic buyer. The ban, scheduled to go into effect at 11:59 p.m. in New York, would have removed TikTok from the app stores run by Apple and Google’s Android, the most widely used marketplaces for downloadable apps. People who don’t yet have the app wouldn’t be able to get it, and those who already have it wouldn’t have access to upd...

FOX NEWS: Miniskirt named 'most iconic fashion statement of all time' in British survey

Miniskirt named 'most iconic fashion statement of all time' in British survey It’s official: Nobody remembers your sweet Members Only jacket from 1983. via FOX NEWS https://ift.tt/2yTg1Dn

Safer Intersections Project a Traffic Calming Success

Safer Intersections Project a Traffic Calming Success By Uyen Ngo This week the San Francisco Municipal Transportation Agency (SFMTA) released “ A Turn Toward Safety: The Safer Intersections Project ,” a report detailing the impact of the Left Turn Traffic Calming Project and the “Safety—It’s Your Turn” education campaign. The Safer Intersections Project now has tested traffic interventions that can reduce unsafe left turns. Overall, SFMTA found a 17% reduction in average speed (1.7mph slower) and a 71% reduction in the likelihood of a car turning left at higher speeds over 15mph at seven high-crash test intersections. In 2019, 40% of traffic deaths in San Francisco were caused when drivers made left turns and didn’t see the person in the crosswalk, until it was too late. To combat this trend, also seen in other cities, and encourage safer left turns and adoption of safer left turn behaviors, San Francisco’s multilayered project combined engineering treatments in seven high-crash ...

New top story from Time: Deaths and Blackouts Have Hit the U.S. Northwest Due to the Unprecedented Heat Wave

https://ift.tt/2UgzckI SPOKANE, Wash. — The unprecedented Northwest U.S. heat wave that slammed Seattle and Portland, Oregon, moved inland Tuesday — prompting a electrical utility in Spokane, Washington, to resume rolling blackouts amid heavy power demand. Officials said a dozen deaths in Washington and Oregon may be tied to the intense heat that began late last week. The dangerous weather that gave Seattle and Portland consecutive days of record high temperatures exceeding 100 degrees Fahrenheit (37.7 degrees Celcius) was expected to ease in those cities. But inland Spokane saw temperatures spike. The National Weather Service said the mercury reached 109 F (42.2 C) in Spokane— the highest temperature ever recorded there. [time-brightcove not-tgx=”true”] About 9,300 Avista Utilities customers in Spokane lost power on Monday and the company said more planned blackouts began on Tuesday afternoon in the city of about 220,000 people. “We try to limit outages to one hour per...

New Express Service Comes to the 1 California

New Express Service Comes to the 1 California By Melissa Culross Newly painted Muni flag stop indicating the pilot 1X California Express Beginning February 21, 2023, a pilot program will offer express bus service on the new 1X California Express between the Richmond neighborhood and the Financial District. The SFMTA plays a significant role in San Francisco’s economic recovery, and this pilot that serves downtown is part of that.  We have been working on improving travel time and reliability over the last several years. Travel times are now 11% quicker on the 1 California thanks to new transit lanes on California, Clay and Sacramento streets. But our work is not done on the corridor! The new 1X California express will provide another option for riders to zoom from the inner Richmond into and out of downtown even faster. We also expect this service to ease crowding on the 1 California as more people head back to the office.  Three morning 1X California Express buses will ...

New top story from Time: President Trump’s Brother, Robert Trump, Dies at 71

https://ift.tt/3g1Evdc (NEW YORK) — President Donald Trump’s younger brother, Robert Trump, a businessman known for an even keel that seemed almost incompatible with the family name, died Saturday night after being hospitalized in New York, the president said in a statement. He was 71. The president visited his brother at a New York City hospital on Friday after White House officials said he had become seriously ill. Officials did not immediately release a cause of death. “It is with heavy heart I share that my wonderful brother, Robert, peacefully passed away tonight,” Donald Trump said in a statement. “He was not just my brother, he was my best friend. He will be greatly missed, but we will meet again. His memory will live on in my heart forever. Robert, I love you. Rest in peace.” The youngest of the Trump siblings had remained close to the 74-year-old president and, as recently as June, filed a lawsuit on behalf of the Trump family that unsuccessfully sought to stop ...

New top story from Time: We Need an Operation Warp Speed for Alzheimer’s and Dementia

https://ift.tt/3aLmKzs No president has entered the White House with as clear a focus on Alzheimer’s disease as Joe Biden. The commitment and attention on Alzheimer’s at the highest levels of our elected leadership is long overdue. His pledge during his victory speech on November 7 to create an America that looks ahead to curing diseases like Alzheimer’s was a beacon of hope to 5.8 million Americans, their families and the 16.1 million caregivers currently devastated by a disease that has no cure. President Biden understands the scope of this slow-moving pandemic, the opportunity, and the consequences of failing to seize the moment. “If we do not find an answer to Alzheimer’s, then in the next 19 years, every single solitary bed that exists in the United States of America now will be occupied by an Alzheimer’s patient,” he said at a campaign stop in Florida last fall. The fact is that Alzheimer’s is already our country’s most expensive disease, and continuing to manage ...

Exciting Changes Coming to San Francisco Taxis!

Exciting Changes Coming to San Francisco Taxis! By Exciting Changes Coming to San Francisco Taxis!  A new way to hail a taxi is coming soon, San Francisco! Yesterday, our MTA Board of Directors approved an amendment to the pilot program to test upfront fares, which was approved back in September 2021. This amendment will now allow Taxi E-Hail app providers to dispatch trips that originate with third-party entities, which may offer upfront fares that are not based on taximeter rates. In other words, you’ll soon be able to pick up your smartphone and check the cost to your destination and book a ride via taxi with a few swipes.   Allowing taxi customers to select a flat rate advance fare is intended to improve customer service, enable customers to price shop among similar services and minimize meter anxiety that occurs when customers feel that the Taximeter rate is increasing beyond their expectation. The price flexibility is intended to increase the number of taxi trips a...